Get the Stockscreener App
8.98
3.96%
-0.37
After Hours:
8.98
Sensei Biotherapeutics Inc stock is traded at $8.98, with a volume of 1,284.
It is down -3.96% in the last 24 hours and up +18.82% over the past month.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
See More
Previous Close:
$9.35
Open:
$9.44
24h Volume:
1,284
Relative Volume:
0.08
Market Cap:
$11.33M
Revenue:
-
Net Income/Loss:
$-29.80M
P/E Ratio:
-7.5462
EPS:
-1.19
Net Cash Flow:
$-25.19M
1W Performance:
+7.93%
1M Performance:
+18.82%
6M Performance:
+1.54%
1Y Performance:
-10.20%
1-Day Range:
$8.9001
$9.44
1-Week Range:
$7.9298
$9.50
52-Week Range:
$5.00
$17.40
Sensei Biotherapeutics Inc Stock (SNSE) Company Profile
Name
Sensei Biotherapeutics Inc
Sector
Industry
Phone
(240) 243-8000
Address
1405 RESEARCH BLVD, SUITE 125, ROCKVILLE
Compare SNSE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNSE
Sensei Biotherapeutics Inc
|
8.98 | 10.72M | 0 | -29.80M | -25.19M | -1.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Sensei Biotherapeutics Inc Stock (SNSE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | H.C. Wainwright | Buy |
| May-14-24 | Initiated | Stephens | Overweight |
| Jul-01-21 | Downgrade | Berenberg | Buy → Hold |
| Jun-29-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Mar-01-21 | Initiated | Berenberg | Buy |
| Mar-01-21 | Initiated | Citigroup | Buy |
| Mar-01-21 | Initiated | Oppenheimer | Outperform |
| Mar-01-21 | Initiated | Piper Sandler | Overweight |
View All
Sensei Biotherapeutics Inc Stock (SNSE) Latest News
Combining price and volume data for Sensei Biotherapeutics Inc.2025 Key Highlights & Low Risk Investment Opportunities - Newser
How to forecast Sensei Biotherapeutics Inc. trends using time seriesStop Loss & Fast Gain Stock Trading Tips - Newser
What machine learning models say about Sensei Biotherapeutics Inc.Weekly Trend Recap & Reliable Price Breakout Signals - Newser
Reversal indicators forming on Sensei Biotherapeutics Inc. stock2025 Trading Recap & Real-Time Chart Pattern Alerts - Newser
Analyzing Sensei Biotherapeutics Inc. with multi timeframe chartsJuly 2025 Trade Ideas & Long-Term Growth Portfolio Plans - Newser
How sentiment analysis helps forecast Sensei Biotherapeutics Inc.Market Movement Recap & Expert Approved Momentum Ideas - Newser
Will Sensei Biotherapeutics Inc. benefit from macro trendsJuly 2025 Movers & Real-Time Volume Analysis - Newser
Will Sensei Biotherapeutics Inc. continue its uptrendQuarterly Profit Report & High Conviction Buy Zone Alerts - Newser
Is Sensei Biotherapeutics Inc. a candidate for recovery playJuly 2025 Recap & Technical Pattern Based Buy Signals - Newser
Tools to monitor Sensei Biotherapeutics Inc. recovery probabilityBond Market & Long-Term Safe Investment Plans - Newser
Technical signs of recovery in Sensei Biotherapeutics Inc.Portfolio Risk Report & Free Technical Pattern Based Buy Signals - Newser
will sensei biotherapeutics inc. benefit from macro trendsPortfolio Gains Summary & Target Return Focused Stock Picks - Newser
Predicting Sensei Biotherapeutics Inc. trend using moving averagesBond Market & Real-Time Stock Entry Alerts - Newser
Developing predictive dashboards with Sensei Biotherapeutics Inc. data2025 Breakouts & Breakdowns & Safe Capital Allocation Plans - Newser
Trend analysis for Sensei Biotherapeutics Inc. this weekTrade Analysis Summary & Safe Entry Point Identification - Newser
Sentiment analysis tools applied to Sensei Biotherapeutics Inc.Index Update & Reliable Price Breakout Alerts - Newser
Sensei Biotherapeutics Inc. stock prediction for this weekPortfolio Risk Report & Fast Exit Strategy with Risk Control - Newser
trend analysis for sensei biotherapeutics inc. this weekPortfolio Risk Summary & AI Powered Market Trend Analysis - Newser
How to recover losses in Sensei Biotherapeutics Inc. stockQuarterly Market Summary & Safe Capital Allocation Plans - Newser
Is Sensei Biotherapeutics Inc. stock entering bullish territoryJuly 2025 Selloffs & Detailed Earnings Play Strategies - Newser
Bullish Candlestick Pattern Forms in Sensei Biotherapeutics Inc.2025 Year in Review & AI Forecasted Stock Moves - beatles.ru
Can Sensei Biotherapeutics Inc. be the next market leaderBear Alert & Weekly Momentum Picks - beatles.ru
Published on: 2025-09-08 11:58:53 - beatles.ru
Is it too late to sell Sensei Biotherapeutics Inc.Trade Risk Summary & Comprehensive Market Scan Insights - Newser
Is Sensei Biotherapeutics Inc. a turnaround storyWeekly Loss Report & Safe Entry Point Identification - 강소기업뉴스
Is Sensei Biotherapeutics Inc. a good ESG investment2025 Valuation Update & Technical Confirmation Trade Alerts - classian.co.kr
Sensei Biotherapeutics Inc Stock (SNSE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):